Pontifax Ltd. is a life sciences venture capital firm that specializes in investing in and nurturing early-stage companies in the healthcare sector. The firm focuses on innovative therapeutics, medical devices, and diagnostics, aiming to address significant unmet medical needs and improve patient care.

Founded in 2004, Pontifax is a healthcare-dedicated venture capital firm with over $1.2 billion under management. We seek transformative, cutting-edge life sciences technologies at all development stages. Pontifax invests in breakthrough innovation regardless of therapeutic area or development stage. We establish our own companies as well as partner with existing managements to nurture start-ups to maturity. Pontifax takes a hands-on approach in its portfolio management and is deeply involved in charting the course of each company.

UroGen Pharma

VBI Vaccines

89bio

Amolyt Pharma

Rewalk Robotics

Check-Cap

Collplant

Prevail Therapeutics

ProQR Therapeutics

Keros Therapeutics

LogicBio Therapeutics

Silverback Therapeutics

Dynacure

Mereo Biopharma

Eloxx

Neogene Therapeutics

Pontifax Venture Capital

Pontifax Ltd.

COM:PONTIFAX

Pontifax Ltd.

Analysis Not Available